I. Morrissey

发表

Surveillance of the susceptibility of ocular bacterial pathogens to the fluoroquinolone gatifloxacin and other antimicrobials in Europe during 2001/2002.

I. Morrissey, R. Burnett, L. Viljoen, 2004, The Journal of infection.

Evaluation of Epidemiological Cut-Off Values Indicates that Biocide Resistant Subpopulations Are Uncommon in Natural Isolates of Clinically-Relevant Microorganisms

I. Morrissey, M. Oggioni, J. Martínez, 2014, PloS one.

A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011

I. Morrissey, M. Hackel, S. Hawser, 2013, Pharmaceuticals.

In vitro activity of ceftaroline and comparator antimicrobials against European and Middle East isolates from complicated skin and skin-structure infections collected in 2008-2009.

I. Morrissey, A. Leakey, J. Northwood, 2012, International journal of antimicrobial agents.

A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection.

I. Morrissey, M. Robbins, D. Farrell, 2003, The Journal of infection.

Dissemination of Novel Antimicrobial Resistance Mechanisms through the Insertion Sequence Mediated Spread of Metabolic Genes

I. Morrissey, Hong-Yu Ou, J. Martínez, 2016, Front. Microbiol..

Discovery of a Novel Metallo-β-Lactamase Inhibitor That Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacteriaceae

I. Morrissey, D. Davies, S. Magnet, 2018, Antimicrobial Agents and Chemotherapy.

Molecular Epidemiology of Multiresistant Streptococcus pneumoniae with Both erm(B)- and mef(A)-Mediated Macrolide Resistance

I. Morrissey, D. Farrell, D. Felmingham, 2004, Journal of Clinical Microbiology.

Prevalence and Molecular Analysis of Macrolide and Fluoroquinolone Resistance among Isolates of Streptococcus pneumoniae Collected during the 2000-2001 PROTEKT US Study

I. Morrissey, Steven D. Brown, D. Farrell, 2004, Journal of Clinical Microbiology.

Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study.

I. Morrissey, D. Farrell, D. Felmingham, 2002, The Journal of antimicrobial chemotherapy.

Detection of macrolide resistance mechanisms in Streptococcus pneumoniae and Streptococcus pyogenes using a multiplex rapid cycle PCR with microwell-format probe hybridization.

I. Morrissey, D. Farrell, D. Felmingham, 2001, The Journal of antimicrobial chemotherapy.

The Use of Machine Learning Methodologies to Analyse Antibiotic and Biocide Susceptibility in Staphylococcus aureus

A. T. Freitas, I. Morrissey, J. Martínez, 2013, PloS one.

The bactericidal activity of levofloxacin compared with ofloxacin, D-ofloxacin, ciprofloxacin, sparfloxacin and cefotaxime against Streptococcus pneumoniae.

I. Morrissey, J. George, 1997, The Journal of antimicrobial chemotherapy.

Bactericidal index: a new way to assess quinolone bactericidal activity in vitro.

I. Morrissey, 1997, The Journal of antimicrobial chemotherapy.

Sigmoid Emax Modeling To Define the Fixed Concentration of Enmetazobactam for MIC Testing in Combination with Cefepime

I. Morrissey, P. Knechtle, S. Shapiro, 2021, Antimicrobial agents and chemotherapy.

Antimicrobial susceptibility of nine udder pathogens recovered from bovine clinical mastitis milk in Europe 2015-2016: VetPath results.

I. Morrissey, B. Valot, D. Hocquet, 2020, Veterinary microbiology.

In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017

I. Morrissey, M. Bassetti, J. Karlowsky, 2019, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of Eravacycline against Gram-Positive Bacteria Isolated in Clinical Laboratories Worldwide from 2013 to 2017

I. Morrissey, M. Bassetti, J. Karlowsky, 2019, Antimicrobial Agents and Chemotherapy.

Results from the Survey of Antibiotic Resistance (SOAR) 2014–16 in Greece

I. Morrissey, J. Papaparaskevas, D. Torumkuney, 2018, The Journal of antimicrobial chemotherapy.

Comparative in vitro antibacterial activity of ozenoxacin against Gram-positive clinical isolates.

I. Morrissey, J. Vila, R. Cantón, 2018, Future microbiology.

Antimicrobial susceptibility monitoring of dermatological bacterial pathogens isolated from diseased dogs and cats across Europe (ComPath results)

I. Morrissey, F. El Garch, H. Moyaert, 2016, Journal of applied microbiology.

Results from the Survey of Antibiotic Resistance (SOAR) 2009-11 in Vietnam.

I. Morrissey, P. H. Vân, D. Torumkuney, 2016, The Journal of antimicrobial chemotherapy.

Results from the Survey of Antibiotic Resistance (SOAR) 2009-11 and 2013-14 in China.

I. Morrissey, F. Hu, F. Wang, 2016, The Journal of antimicrobial chemotherapy.

Antibacterial resistance among children with community-acquired respiratory tract infections (PROTEKT 1999-2000).

I. Morrissey, D. Farrell, D. Felmingham, 2004, The Journal of infection.

Epidemiology and mechanisms of resistance among respiratory tract pathogens.

F. Baquero, I. Morrissey, P. Courvalin, 1998, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Results from the Survey of Antibiotic Resistance (SOAR) 2014–16 in Bulgaria, Romania, Serbia and Croatia

I. Morrissey, R. Vatcheva-Dobrevska, D. Torumkuney, 2018, The Journal of antimicrobial chemotherapy.

Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Bulgaria, Romania, Serbia and Croatia.

I. Morrissey, R. Vatcheva-Dobrevska, D. Torumkuney, 2018, The Journal of antimicrobial chemotherapy.

In vitro Activity of Isavuconazole and Comparators Against Clinical Isolates of Molds from a Multicenter Study in China

I. Morrissey, M. Xiao, J. Aram, 2022, Infection and drug resistance.

In vitro activity of doripenem and other carbapenems against contemporary Gram-negative pathogens isolated from hospitalised patients in the Asia-Pacific region: results of the COMPACT Asia-Pacific Study.

I. Morrissey, P. Kiratisin, R. Flamm, 2010, International journal of antimicrobial agents.

Antimicrobial susceptibility monitoring of mastitis pathogens isolated from acute cases of clinical mastitis in dairy cows across Europe: VetPath results.

I. Morrissey, F. El Garch, S. Simjee, 2015, International journal of antimicrobial agents.

Evaluation of Reduced Susceptibility to Quaternary Ammonium Compounds and Bisbiguanides in Clinical Isolates and Laboratory-Generated Mutants of Staphylococcus aureus

A. T. Freitas, I. Morrissey, G. Orefici, 2013, Antimicrobial Agents and Chemotherapy.

Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in Turkey.

I. Morrissey, Z. Aktaş, S. Aydemir, 2016, The Journal of antimicrobial chemotherapy.

Molecular Characterization and Antimicrobial Susceptibility of Fluoroquinolone-Resistant or -Susceptible Streptococcus pneumoniae from Hong Kong

I. Morrissey, D. Farrell, D. Felmingham, 2003, Antimicrobial Agents and Chemotherapy.

A novel resistance mechanism to triclosan that suggests horizontal gene transfer and demonstrates a potential selective pressure for reduced biocide susceptibility in clinical strains of Staphylococcus aureus.

R. Fani, A. T. Freitas, I. Morrissey, 2012, International journal of antimicrobial agents.

Engineered peptide PLG0206 overcomes limitations of a challenging antimicrobial drug class

I. Morrissey, R. Montelaro, P. Ghahramani, 2022, PloS one.

Antibiotic susceptibility in Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes in Pakistan: a review of results from the Survey of Antibiotic Resistance (SOAR) 2002-15.

I. Morrissey, R. Hasan, N. Mahmood, 2016, The Journal of antimicrobial chemotherapy.

Activity of iclaprim against Legionella pneumophila.

I. Morrissey, S. Hawser, 2007, The Journal of antimicrobial chemotherapy.

Surveillance of the activity of solithromycin (CEM-101) against bacteria from respiratory tract infections.

I. Morrissey, K. Keedy, S. Hawser, 2017, International journal of antimicrobial agents.

Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in Ukraine.

I. Morrissey, G. Gladka, Y. Feshchenko, 2016, The Journal of antimicrobial chemotherapy.

Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in the Middle East (Kuwait, Lebanon and Saudi Arabia): data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.

I. Morrissey, A. Jiman-Fatani, Z. Daoud, 2020, The Journal of antimicrobial chemotherapy.

Non-susceptibility trends among Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections in the UK and Ireland, 1999-2007.

I. Morrissey, R. Reynolds, L. Williams, 2008, The Journal of antimicrobial chemotherapy.

Global distribution of TEM-1 and ROB-1 β-lactamases in Haemophilus influenzae

I. Morrissey, D. Farrell, D. Felmingham, 2005 .

Macrolide Resistance by Ribosomal Mutation in Clinical Isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 Study

J. Poehlsgaard, S. Douthwaite, I. Morrissey, 2003, Antimicrobial Agents and Chemotherapy.

In Vitro Global Surveillance of Eravacycline and Comparators against Staphylococcus spp. and Enterococcus spp. Over a Three-year Period (2013-15)

I. Morrissey, M. Bassetti, T. Grossman, 2016 .

Serial passage of Chlamydia spp. in sub-inhibitory fluoroquinolone concentrations.

G. Ridgway, I. Morrissey, D. Farrell, 2002, The Journal of antimicrobial chemotherapy.

Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzae.

I. Morrissey, G. Tillotson, 2004, The Journal of antimicrobial chemotherapy.

Results from the Survey of Antibiotic Resistance (SOAR) 2011-14 in the Democratic Republic of Congo, Ivory Coast, Republic of Senegal and Kenya.

I. Morrissey, A. Seck, G. Revathi, 2016, The Journal of antimicrobial chemotherapy.

Results from the Survey of Antibiotic Resistance (SOAR) 2002-09 in Turkey.

I. Morrissey, Z. Aktaş, D. Gür, 2016, The Journal of antimicrobial chemotherapy.

Activities of Fluoroquinolones againstStreptococcus pneumoniae Type II Topoisomerases Purified as Recombinant Proteins

I. Morrissey, J. George, 1999, Antimicrobial Agents and Chemotherapy.

Bactericidal activity of gemifloxacin and other quinolones against Streptococcus pneumoniae.

I. Morrissey, J. George, 2000, The Journal of antimicrobial chemotherapy.

Antimicrobial Susceptibility Monitoring of Bacterial Pathogens Isolated from Urinary Tract Infections in Dogs and Cats Across Europe: ComPath Results.

I. Morrissey, F. El Garch, H. Moyaert, 2017, Microbial drug resistance.

TARGETed surveillance: susceptibility of Streptococcus pneumoniae isolated from community-acquired respiratory tract infections in 2003 to fluoroquinolones and other agents.

I. Morrissey, J. Northwood, A. Colclough, 2007, International journal of antimicrobial agents.

The importance of oxygen in the killing of bacteria by ofloxacin and ciprofloxacin.

I. Morrissey, J. Smith, Smith Jt, 1994, Microbios.

Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition

I. Morrissey, K. Sato, J. Kato, 1994, Antimicrobial Agents and Chemotherapy.

Mechanism of differential activities of ofloxacin enantiomers

I. Morrissey, M. Bures, A. Yoshida, 1996, Antimicrobial agents and chemotherapy.

Bactericidal activity of the new 4-quinolones DU-6859a and DV-7751a.

I. Morrissey, J. Smith, 1995, Journal of medical microbiology.

Bactericidal activity of trovafloxacin (CP-99,219).

I. Morrissey, 1996, The Journal of antimicrobial chemotherapy.

Purification of pneumococcal type II topoisomerases and inhibition by gemifloxacin and other quinolones.

I. Morrissey, J. George, 2000, The Journal of antimicrobial chemotherapy.

Inhibition of Pneumococcal Topoisomerases by Sitafloxacin

I. Morrissey, J. George, 1999, Drugs.

Survey of antimicrobial susceptibility of bacterial pathogens isolated from dogs and cats with respiratory tract infections in Europe: ComPath results

I. Morrissey, M. Rzewuska, F. El Garch, 2019, Journal of applied microbiology.

Antimicrobial susceptibility monitoring of canine and feline skin and ear pathogens isolated from European veterinary clinics: results of the ComPath Surveillance programme.

I. Morrissey, F. El Garch, S. Simjee, 2020, Veterinary dermatology.

Erratum: Survey of antimicrobial susceptibility of bacterial pathogens isolated from dogs and cats with respiratory tract infections in Europe: ComPath results

I. Morrissey, M. Rzewuska, F. El Garch, 2019, Journal of applied microbiology.

Antimicrobial susceptibility monitoring of bacterial pathogens isolated from respiratory tract infections in dogs and cats across Europe: ComPath results.

I. Morrissey, F. El Garch, H. Moyaert, 2016, Veterinary microbiology.

Evaluation of the Clinical and Laboratory Standards Institute phenotypic confirmatory test to detect the presence of extended-spectrum β-lactamases from 4005 Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae and Proteus mirabilis isolates.

I. Morrissey, M. Hackel, D. Hoban, 2014, Journal of medical microbiology.

Surveillance of the Activity of Aminoglycosides and Fluoroquinolones Against Ophthalmic Pathogens from Europe in 2010–2011

I. Morrissey, T. Morris, C. Sanfilippo, 2015, Current eye research.

The MUT056399 Inhibitor of FabI Is a New Antistaphylococcal Compound

I. Morrissey, F. Moreau, S. Escaich, 2011, Antimicrobial Agents and Chemotherapy.

Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme.

I. Morrissey, M. Enright, R. Cantón, 2003, The Journal of antimicrobial chemotherapy.

Novel Specific Metallo-β-Lactamase Inhibitor ANT2681 Restores Meropenem Activity to Clinically Effective Levels against NDM-Positive Enterobacterales

I. Morrissey, D. Davies, M. Lemonnier, 2021, Antimicrobial Agents and Chemotherapy.

Discovery of ANT3310, a Novel Broad-Spectrum Serine β-Lactamase Inhibitor of the Diazabicyclooctane Class, Which Strongly Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacterales and Acinetobacter baumannii.

I. Morrissey, D. Davies, S. Mangani, 2020, Journal of medicinal chemistry.

Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in Turkey: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.

I. Morrissey, Z. Aktaş, B. Sancak, 2020, The Journal of antimicrobial chemotherapy.

Activity of the new cephalosporin ceftaroline against bacteraemia isolates from patients with community-acquired pneumonia.

I. Morrissey, Yigong Ge, R. Janes, 2009, International journal of antimicrobial agents.

In Vitro Activity of Cefepime-Enmetazobactam against Gram-Negative Isolates Collected from U.S. and European Hospitals during 2014–2015

I. Morrissey, S. Magnet, P. Knechtle, 2019, Antimicrobial Agents and Chemotherapy.

Results from the Survey of Antibiotic Resistance (SOAR) 2012–14 in Thailand, India, South Korea and Singapore

I. Morrissey, T. Tan, C. Rodrigues, 2016, The Journal of antimicrobial chemotherapy.

The Influence of Oxygen upon Bactericidal Potency

I. Morrissey, J. Smith, C. Lewin, 1990 .

The mode of action of quinolones: The paradox in activity of low and high concentrations and activity in the anaerobic environment

I. Morrissey, J. Smith, C. Lewin, 1991, European Journal of Clinical Microbiology and Infectious Diseases.

A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum model.

I. Morrissey, S. Gillespie, D. Everett, 2001, Journal of medical microbiology.

Antimicrobial susceptibility monitoring of respiratory tract pathogens isolated from diseased cattle and pigs across Europe: the VetPath study.

I. Morrissey, F. El Garch, S. Simjee, 2014, Veterinary microbiology.

Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.

I. Morrissey, H. Weiher, M. Kresken, 2007, International Journal of Antimicrobial Agents.

Comparative activity of carbapenem testing: the COMPACT study.

I. Morrissey, P. Nordmann, R. Mutters, 2011, The Journal of antimicrobial chemotherapy.

Comparative Activity of Carbapenem Testing (COMPACT) study in Germany.

I. Morrissey, G. Valenza, H. Seifert, 2012, International journal of antimicrobial agents.

The effect of the inoculum size on bactericidal activity.

I. Morrissey, J. George, 1999, The Journal of antimicrobial chemotherapy.

Mutations upstream of fabI in triclosan resistant Staphylococcus aureus strains are associated with elevated fabI gene expression

I. Morrissey, C. Largiadèr, M. Oggioni, 2015, BMC Genomics.

Lack of Evidence for Reduced Fitness of Clinical Staphylococcus aureus Isolates with Reduced Susceptibility to Triclosan

I. Morrissey, G. Orefici, M. Oggioni, 2012, Antimicrobial Agents and Chemotherapy.

In Vitro Activities of Telithromycin, Linezolid, and Quinupristin-Dalfopristin against Streptococcus pneumoniae with Macrolide Resistance Due to Ribosomal Mutations

I. Morrissey, D. Farrell, D. Felmingham, 2004, Antimicrobial Agents and Chemotherapy.

694. In vitro Antibacterial Activity of Sulbactam–Durlobactam (ETX2514SUL) Against 121 Recent Acinetobacter baumannii Isolated from Patients in India

I. Morrissey, S. McLeod, Alita A. Miller, 2019, Open Forum Infectious Diseases.

1359. Activity of Meropenem/Nacubactam Combination Against Gram-Negative Clinical Isolates: ROSCO Global Surveillance 2017

I. Morrissey, F. García-Alcalde, A. Haldimann, 2018, Open Forum Infectious Diseases.

Results from the Survey of Antibiotic Resistance (SOAR) 2014–16 in Russia

I. Morrissey, S. Sidorenko, M. Edelstein, 2018, The Journal of antimicrobial chemotherapy.

Results from the Survey of Antibiotic Resistance (SOAR) 2015-18 in Tunisia, Kenya and Morocco: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.

I. Morrissey, A. Hammami, G. Revathi, 2020, The Journal of antimicrobial chemotherapy.

Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in the Gulf States.

I. Morrissey, Z. Daoud, A. Rafay, 2016, The Journal of antimicrobial chemotherapy.

Results from the Survey of Antibiotic Resistance (SOAR) 2016-18 in Vietnam, Cambodia, Singapore and the Philippines: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.

I. Morrissey, S. H. Tan, S. Koo, 2020, The Journal of antimicrobial chemotherapy.

Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and β-haemolytic streptococci collected from western European countries in 2011.

I. Morrissey, P. Nordmann, A. MacGowan, 2013, The Journal of antimicrobial chemotherapy.

In Vitro Global Surveillance of Eravacycline and Comparators Against Enterobacteriaceae, Acinetobacter baumannii, Stenotrophomonas maltophilia, Including Multidrug-Resistant (MDR) Isolates, Over a 3-Year Period (2013–2015)

I. Morrissey, M. Bassetti, T. Grossman, 2016 .

Comparative activity of ceftobiprole against Gram-positive and Gram-negative isolates from Europe and the Middle East: the CLASS study.

I. Morrissey, G. Rossolini, R. Flamm, 2011, The Journal of antimicrobial chemotherapy.

Results from the Survey of Antibiotic Resistance (SOAR) 2012-14 in Thailand, India, South Korea and Singapore.

I. Morrissey, T. Tan, C. Rodrigues, 2016, The Journal of antimicrobial chemotherapy.

Activity of iclaprim against clinical isolates of Streptococcus pyogenes and Streptococcus agalactiae.

I. Morrissey, S. Hawser, K. Maher, 2008, The Journal of antimicrobial chemotherapy.

Quinupristin-Dalfopristin Resistance in Streptococcus pneumoniae: Novel L22 Ribosomal Protein Mutation in Two Clinical Isolates from the SENTRY Antimicrobial Surveillance Program

Ronald N. Jones, I. Morrissey, D. Farrell, 2003, Antimicrobial Agents and Chemotherapy.

Significant Differences Characterise the Correlation Coefficients between Biocide and Antibiotic Susceptibility Profiles in Staphylococcus aureus

A. T. Freitas, I. Morrissey, J. Martínez, 2015, Current pharmaceutical design.

Results from the Survey of Antibiotic Resistance (SOAR) 2016-17 in Ukraine: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.

I. Morrissey, D. Torumkuney, T. Pertseva, 2020, The Journal of antimicrobial chemotherapy.

Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in Latin America (Argentina, Chile and Costa Rica): data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.

I. Morrissey, A. Sucari, M. Pennini, 2020, The Journal of antimicrobial chemotherapy.

Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in Pakistan: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.

I. Morrissey, N. Malik, D. Torumkuney, 2020, The Journal of antimicrobial chemotherapy.

The Fluoroquinolones Exert a Reduced Rate of Kill Against Enterococcus faecalis

I. Morrissey, J. Smith, C. Lewin, 1991, The Journal of pharmacy and pharmacology.

Activity of Quinolone Antibacterials against Streptococcus pneumoniae

I. Morrissey, J. Smith, 1993, Drugs.

Third-generation cephalosporin resistance in clinical isolates of Enterobacterales collected between 2016-2018 from USA and Europe: genotypic analysis of β-lactamases and comparative in vitro activity of cefepime/enmetazobactam.

I. Morrissey, P. Knechtle, S. Hawser, 2021, Journal of global antimicrobial resistance.

Novel insight into antimicrobial resistance and sensitivity phenotypes associated to qac and norA genotypes in Staphylococcus aureus.

I. Morrissey, D. Mora, M. Oggioni, 2015, Microbiological research.

Epidemiology and antimicrobial susceptibility of Gram-negative aerobic bacteria causing intra-abdominal infections during 2010–2011

I. Morrissey, M. Hackel, D. Hoban, 2015, Journal of chemotherapy.

Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods.

I. Morrissey, L. Viljoen, M. Robbins, 2005, The Journal of antimicrobial chemotherapy.

Efficacy Evaluation of Iclaprim in a Neutropenic Rat Lung Infection Model with Methicillin-Resistant Staphylococcus aureus Entrapped in Alginate Microspheres

I. Morrissey, S. Hawser, David B. Huang, 2017, European Journal of Clinical Microbiology & Infectious Diseases.

This is a repository copy of Efficacy evaluation of iclaprim in a neutropenic rat lung infection model with methicillin-resistant Staphylococcus aureus entrapped in alginate

I. Morrissey, M. Wilcox, S. Hawser, 2018 .

Global distribution of TEM-1 and ROB-1 beta-lactamases in Haemophilus influenzae.

I. Morrissey, D. Farrell, D. Felmingham, 2005, The Journal of antimicrobial chemotherapy.

Evaluation of Reduced Susceptibility to Quaternary Ammonium Compounds and Bisbiguanides in Clinical Isolates and Laboratory-Generated Mutants of Staphylococcus aureus

A. T. Freitas, I. Morrissey, G. Orefici, 2013, Antimicrobial Agents and Chemotherapy.

Prevalence and Molecular Analysis of Macrolide and Fluoroquinolone Resistance among Isolates of Streptococcus pneumoniae Collected during the 2000-2001 PROTEKT US Study

I. Morrissey, Steven D. Brown, D. Farrell, 2004, Journal of Clinical Microbiology.

ME1036, a novel carbapenem, with enhanced activity against clinical isolates causing bacteraemic community-acquired pneumonia.

I. Morrissey, D. Biek, R. Janes, 2009, The Journal of antimicrobial chemotherapy.